Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in PMCB — PharmaCyte Biotech, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in PMCB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$34,536
+$4,446 QoQ
Shares Held
44,853
+62.5% QoQ
Ownership
0.418%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 30 holders
Holding Since
Sep 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PMCB Over Time

Shares Held

Position Value (USD)

Derivatives in PMCB

reported options exposure · as of Mar 31, 2023
CallValue
$34,047
CallShares
11,700
PutValue
$116,109
PutShares
39,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. PMCB ranks #304 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PMCB

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $34,536 44,853
2025-06-30 $30,090 27,606
2025-03-31 $23,007 18,406
2024-12-31 $54,135 34,481
2024-09-30 $67,285 35,228
2024-06-30 $107,474 54,834
2024-03-31 $97,615 41,188
2023-12-31 $47,580 22,028
2023-03-31 $34,047 11,700
2023-03-31 $116,109 39,900
2023-03-31 $311,038 106,886
2022-12-31 $105,773 36,100
2022-12-31 $108,117 36,900
2022-09-30 $39,897 16,624
2022-09-30 $174,720 72,800
2022-09-30 $83,280 34,700
2022-06-30 $176,084 78,609
2022-06-30 $343,168 153,200
2022-03-31 $64,542 28,062
2022-03-31 $98,900 43,000
2021-12-31 $71,250 28,500
2021-09-30 $95,417 30,100